Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEuropa Oil & Gas Regulatory News (EOG)

Share Price Information for Europa Oil & Gas (EOG)

Share Price is delayed by 15 minutes
Get Live Data
1.375    0.00 (0.00%)
Bid:
1.30
Ask:
1.45
Spread: 0.15 (11.538%)
Market Cap: £18.10m
EOG Live PriceLast checked at - London Stock Exchange

Intraday Europa Oil & Gas Share Chart

POST TRANSACTION REPORT

5 Mar 2026 14:00

RNS Number : 5497V
Europa Oil & Gas (Holdings) PLC
05 March 2026
 

 

POST TRANSACTION REPORT

Name of Issuer

Europa Oil & Gas (Holdings) PLC

Transaction details

Placing by ABB:

291,667,000 new Ordinary shares of nominal value 1 pence at 1.2 pence each with 1 for 4 warrants with exercise price of 2 pence and expiry 2 years after admission of the new shares to AIM.

This represents approximately 30% of pre fundraising ISC and 22% of post fundraising ISC.

 

Retail offer to existing shareholders only:

53,431,408 new Ordinary shares on same basis as the Placing with same warrants attaching.

This represents approximately 6% of pre fundraising ISC and 4% of post fundraising ISC.

 

Quantum of the proceeds

Placing - £3,500,004 gross

Retail offer - £641,167.89 gross

 

Total gross proceeds £4,141,171.89

 

Discount

Approximately 20% to the closing bid price of an ordinary share the day before announcement of the placing.

 

The accompanying 1:4 warrants have an exercise price at a 67% premium to the placing price.

Allocations

The Board and management were directly involved in the allocation process, reviewing the subscriptions on a line-by-line basis with guidance from the Winterflood team. In doing so, we were mindful both of enabling participating shareholders to "stand their corner" as much as possible and also of the participating Nominees' and brokers' duty to treat their clients fairly and equitably. As such, the vast majority of subscribers were allocated on the same basis with a few exceptions, being:

· Known market makers were removed

· "true" retail platforms were given a larger percentage than discretionary wealth managers

· A couple of subscribers whose applications were well out of proportion with their existing shareholding were scaled back in order to bring their allocation more in line with other shareholders in terms of percentage of existing shareholding.

Consultation

A number of shareholders of over 1%, who were willing to be brought inside and therefore comply with the MAR and AIM rules associated with being privy to market sensitive information, were consulted prior to the launch of the placing. In total such shareholders represented 21% of the company's ISC.

Retail Investors

The directors of the company considered the impact on existing retail investors at all stages of the fundraising.

 

It was the belief of the Board that the full amount of funds needed, being over £3.5m could not be raised via a retail offer alone. It was further felt that attracting more institutional investment that would be likely to stay with the company over the medium term would also be beneficial. An ABB was used to ensure that the highest price possible was achieved. thereby minimising the dilutive effect to all existing shareholders.

 

The retail offer, originally intended to raise £350,000, was multiple times over-subscribed. Whilst the directors wanted to include these subscribers to the fullest extent possible, it was decided to scale back these subscriptions to a little over £640,000. This decision was made on the basis that the company does not currently have an identified use for the full subscription amount, and in order not to further dilute those existing shareholders who did not or could not take part.

 

The retail offer was scaled back in a similar proportion to that which the placing was. Management was directly involved in the allocation of the retail offer. Known market makers were removed; we sought to give priority to "true" retail investors and consistently applied scale back other than a few examples where the subscription was well out of proportion with current holdings.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEADDSESSKEFA
Date   Source Headline
27th Jan 20257:00 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSChange in Registered Office
18th Dec 20247:00 amRNSWhisby - Net Profits Agreement Terminated
12th Dec 20247:00 amRNSBoard Changes
29th Nov 20241:53 pmRNSResult of AGM
28th Nov 20247:00 amRNS-RNotice of Investor Presentation and Q&A
12th Nov 20247:00 amRNSWressle Planning Update
4th Nov 20247:00 amRNSNotice of AGM and Posting of Annual Report
30th Oct 20242:41 pmRNSDirector/PDMR Dealing
28th Oct 20247:00 amRNSFinal results for the year to 31 July 2024
18th Oct 20247:00 amRNSWressle Planning Update
17th Oct 20247:00 amRNSResponse to media speculation
16th Sep 20247:00 amRNSWressle - Receipt of Planning Approval
13th Sep 202410:05 amRNSP2358 Licence (Serenity) update
22nd Jul 20241:17 pmRNSDirector/PDMR Dealing
22nd Jul 20247:00 amRNSEG-08 Revised Prospective Resources
16th Jul 20247:00 amRNSHolding(s) in Company
24th Jun 20247:00 amRNSChange of Nominated Adviser
7th May 20247:00 amRNSRetail Investor Reception
3rd May 20247:00 amRNS33rd Licensing Round Update
22nd Apr 20247:00 amRNSUpdated Irish Licence Emissions Report
17th Apr 20249:41 amRNSDirector/PDMR Dealing
17th Apr 20247:00 amRNSInterim Results
8th Apr 20247:00 amRNSBoard Change
5th Mar 202410:31 amRNSDirector/PDMR Dealing
15th Feb 20241:37 pmRNSHolding(s) in Company
14th Feb 20247:00 amRNSExtension of PEDL 343 Licence (Cloughton)
29th Jan 20247:00 amRNSFEL 4/19 Licence Extension Approval
19th Jan 20247:00 amRNSAward & Concurrent Cancellation of Options
18th Jan 20246:08 pmRNSHolding(s) in Company
15th Jan 20247:00 amRNSWressle Production Update – PEDL180/182
5th Jan 20243:33 pmRNSDirector/PDMR Dealing
2nd Jan 20247:00 amRNSPEDL 180 and PEDL 182 Competent Person’s Report
21st Dec 202311:09 amRNSDirector/PDMR Dealing
21st Dec 20237:01 amRNSBoard Changes
21st Dec 20237:00 amRNSAcquisition of Interest in EG-08 Licence
19th Dec 20237:00 amRNSWressle Production Update – PEDL180/182
29th Nov 202311:05 amRNSWressle Operator Community Update
27th Nov 20237:00 amRNSAttempted Requisition of General Meeting
23rd Nov 20236:05 pmRNSResult of AGM
23rd Nov 20237:00 amRNSWithdrawal of AGM Resolutions
8th Nov 20237:00 amRNSWressle Production Resumes – PEDL180/182
6th Nov 20237:00 amRNSNotice of Investor Presentation
30th Oct 20237:00 amRNSNotice of AGM & Posting of Annual Report
23rd Oct 202310:59 amRNSDirector/PDMR Dealing
23rd Oct 20237:00 amRNSFinal Results
18th Oct 20237:00 amRNSWressle Update
4th Oct 20237:00 amRNSSerenity Update
2nd Oct 20237:00 amRNSFEL 4/19 Update
11th Sep 20237:00 amRNSCloughton Gas in Place Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.